RetroSense Therapeutics
Latest round
- Series B
Last raised
- Nov 2015
Total raised
- $12M
Investors
- 9
About RetroSense Therapeutics
Founded in 2009 and based in Michigan, US, RetroSense Therapeutics, LLC develops gene therapeutics that provides functional vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration.
Who invested in RetroSense Therapeutics
9 investors across 2 rounds
See all investors in RetroSense Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RetroSense Therapeutics
Who invested in RetroSense Therapeutics?
RetroSense Therapeutics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RetroSense Therapeutics raised?
RetroSense Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did RetroSense Therapeutics last raise money?
RetroSense Therapeutics's most recent round on record is a Series B, in Nov 2015.
What does RetroSense Therapeutics do?
Founded in 2009 and based in Michigan, US, RetroSense Therapeutics, LLC develops gene therapeutics that provides functional vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration.
Where is RetroSense Therapeutics headquartered?
RetroSense Therapeutics is headquartered in Ann Arbor, US.
Which VCs invest in companies like RetroSense Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at RetroSense Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like RetroSense Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.